Web Analytics

3 Latest Announced Rounds

$13,509.83M Raised in 76 Funding Rounds in the past 7 Days - View All

Funding Round Profile

Huma

start up
United Kingdom - London
  • 17/07/2024
  • Series D
  • $80,000,000

Huma is a global digital health technology company that uses AI to advance digital-first care delivery and research to help people live longer, fuller lives.

Huma's regulated Software as a Medical Device is the only disease agnostic platform to hold both EU MDR Class IIb and US FDA Class II regulatory status. It powers:

- Digital first care for health systems
- Companion apps to support patients through treatment and drug therapies
- Virtual clinical trials to accelerate research

Please visit www.huma.com to learn more.


Related People

Dan VahdatFounder

Dan Vahdat United States - New York, New York

Dan Vahdat is the founder and CEO of Huma Therapeutics, a global healthcare AI company on a mission to accelerate the adoption of digital solutions in care and research.

Huma’s technology has powered over 3,000 hospitals and clinics. The platform has been used to engage and screen over 35 million individuals, with 1.8 million active users across its various products in 70+ countries. The company is renowned for its role in major national healthcare projects worldwide, from the US and the UK to Germany, Greece, and Saudi Arabia, as well as collaborating with most large pharma companies.

Dan started his journey as a PhD student at Johns Hopkins and has since raised over $200 million in funding, driving Huma to its leading position today.

He is widely recognized as a trailblazer, innovator, and entrepreneur: HealthTech Leader of the Year 2023, twice named one of FT Europe’s fastest-growing companies (2021 & 2023), two-time winner of the Prix Galien, and more. Dan is also a member of the World Economic Forum, part of the Global Innovators & Tech Pioneers, as well as the Unicorn Community.

https://www.linkedin.com/in/danvahdat/
https://www.instagram.com/dan.vahdat/
https://www.huma.com/dan